NATHAN BINING: Open Payments
NPI 1538102165 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,604 in 62 payments from 12 companies in 2025. Trend: 2023 $638 · 2024 $1,092 · 2025 $1,604
Food & beverage: $1,604
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $368 |
| GlaxoSmithKline, LLC. | 6 | $330 |
| AstraZeneca Pharmaceuticals LP | 10 | $309 |
| Indivior Inc. | 11 | $176 |
| ABBVIE INC. | 1 | $125 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $95 |
| Exact Sciences Corporation | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Averitas Pharma Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
Products named: CAPLYTA, AREXVY, SUBLOCADE, BREZTRI, VRAYLAR, JOURNAVX, SHINGRIX, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
